Trial intelligence / Profile preview

Raltegravir Regimens in Treatment-Naïve HIV-1

NCT00654147Phase 2Completed

Start
Apr 2008
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1). Started Apr 2008; status: completed.

02

Drugs

raltegravir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00654147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00654147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call